- active not recruitingPHASE3
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
This study is testing a new medicine, ianalumab, for people with active Sjögren's syndrome. Researchers want to see if it's safe and helps improve symptoms. Participants will receive either the new medicine or a dummy medicine called a placebo.
United States · Argentina · Australia - recruiting
Rare AutoImmune SElf-management Programme Development
This study aims to develop a support program for people with rare autoimmune diseases like lupus and vasculitis. It asks patients and healthcare teams across the UK what kind of support is needed to help people manage their conditions and improve their quality of life.
United Kingdom